Jacques Quilici

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

Thomas Cuisset, Pierre Deharo, Jacques Quilici et al. · European Heart Journal · 2017 · 393 citations · Full text

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

T. Cuisset, Corinne Frère, Jacques Quilici et al. · Journal of Thrombosis and Haemostasis · 2005 · 367 citations

Percutaneous Coronary Intervention, Thrombosis, Dual Antiplatelet Therapy +10

Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting

Thomas Cuisset, Corinne Frère, Jacques Quilici et al. · Journal of the American College of Cardiology · 2006 · 343 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +12

Comparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose

Thomas Cuisset, Corinne Frère, Jacques Quilici et al. · Journal of the American College of Cardiology · 2009 · 223 citations

Medicine, Pharmacotherapy, Pharmacology +1

Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome

Corinne Frère, Thomas Cuisset, Pierre‐Emmanuel Morange et al. · The American Journal of Cardiology · 2008 · 209 citations

Thrombopoiesis, Thrombosis, Cardiovascular Disease +12